Pivotal Study Confirms eSense as Effective Digital Program for Women’s Sexual Health
Vancouver, Canada eSense Health Inc. is proud to announce the publication of a pivotal randomized clinical trial in the peer-reviewed journal Behaviour Research & Therapy, validating the efficacy of its flagship product, eSense—a digital program designed to support women experiencing Female Sexual Interest/Arousal Disorder (SIAD), a condition that affects up to 40% of women. Sexual concerns such as low desire, arousal challenges, and discomfort during intimacy are common and often linked to life changes like pregnancy, menopause, cancer, or a history of sexual trauma. Yet less than 20% of affected women receive treatment due to stigma, lack of awareness, long waitlists, and limited access to trained providers. Most healthcare professionals receive minimal formal training in sexual health, leaving a major gap in care. eSense was developed to address this gap. The platform delivers evidence-based Cognitive Behavioral Therapy (CBT) and Mindfulness-Based Therapy (MBT) through interactive, self-guided modules that women can complete